Skip to main content

MoneyWorks4Me

Raymed Labs informs about quarterly statement of investor complaints

12 Jul 2016 Evaluate

Raymed Labs has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Uflex 599.30
EPL 224.10
AGI Greenpac 675.40
Huhtamaki India 221.10
TCPL Packaging 4465.50
View more..